Helen Leask

News

How Aspirin May Lower Risk for Colorectal Cancer

Author:: Helen Leask

Publish date: July 15, 2024

These new data suggest that aspirin helps activate the immune system, which helps explain its potential chemopreventive effect in CRC.

Read More

News

New Trials in Lung Cancer: Could Your Patients Benefit?

Author:: Helen Leask

Publish date: June 25, 2024

A number of lung cancer trials are recruiting for NSCLC which is locally advanced, metastatic, and with or without mutations.

Read More

News

New Trials in Prostate Cancer: Could Your Patient Benefit?

Author:: Helen Leask

Publish date: April 8, 2024

Two new trials for patients with metastatic castration-resistant prostate cancer that involve remaining on therapy until disease progression descri...

Read More

News

Combining Targeted Drugs and Radiation in Breast Cancer: What’s Safe?

Author:: Helen Leask

Publish date: March 18, 2024

What is known and unknown about combining radiotherapy and systemic treatments in breast cancer?

Read More

News

New Trials in Leukemia and Lymphoma: Could Your Patient Benefit?

Author:: Helen Leask

Publish date: February 28, 2024

Adults with previously untreated follicular lymphoma or diffuse large B-cell lymphoma may be eligible to participate in one of three randomized, ph...

Read More

News

New Trials in Gynecologic Cancers: Could Your Patient Benefit?

Author:: Helen Leask

Publish date: February 15, 2024

Several trials are enrolling for patients with gynecologic cancers, which could be appropriate for a range of patients.

Read More

News

Optimal Follow-up After Fertility-Sparing Cervical Cancer Surgery

Author:: Helen Leask

Publish date: January 9, 2024

Investigators sought to find out if follow-up could be tailored to the patient’s risk for recurrence.

Read More

News

Is there a link between esophageal risk and sleep habits?

Author:: Helen Leask

Publish date: July 3, 2023

Too much or too little sleep, daytime naps, and other sleep patterns may increase the risk of developing esophageal cancer.

Read More

News

Cervical screening often stops at 65, but should it?

Author:: Helen Leask

Publish date: April 4, 2023

A new study is intended to provide a more solid foundation for the benefits and harms of cervical screening for women older than 65.

Read More

News

Taking a break from TKIs unlikely to shorten survival

Author:: Helen Leask

Publish date: March 8, 2023

The results of a new study showed that taking an occasional respite from TKI therapy had little impact on a patient’s survival.

Read More

News

Could your patients benefit? New trials in lung cancer

Author:: Helen Leask

Publish date: February 22, 2023

Patients with untreated advanced non–small cell lung cancer (NSCLC) can join one of these randomized, open-label, phase 3 studies.

Read More

News

Cervical cancer rise in White women: A ‘canary in the coal mine’

Author:: Helen Leask

Publish date: January 3, 2023

“If rising incidence is not for localized-stage disease, but for advanced stages, that means it’s attributable to lack of screening.”

Read More

News

Could your patient benefit? New trials in lung cancer

Author:: Helen Leask

Publish date: November 14, 2022

New lung cancer trials.

Read More

News

Could your patients benefit? New trials in noncolorectal GI cancer

Author:: Helen Leask

Publish date: September 30, 2022

Several new trials have launched.

Read More

News

Pregnancy, breastfeeding, and more linked to lower CRC risk

Author:: Helen Leask

Publish date: July 13, 2022

Interestingly, the reduced risk of CRC observed for pregnancy and breastfeeding only applied to proximal colon cancer.

Read More